{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:53:41Z","timestamp":1761548021452,"version":"build-2065373602"},"reference-count":25,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T00:00:00Z","timestamp":1354233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["openneurologyjournal.com","benthamopen.com"],"crossmark-restriction":true},"short-container-title":["TONEUJ"],"published-print":{"date-parts":[[2012,11,30]]},"abstract":"<jats:p>Since the identification of the causative organism more than 30 years ago, there remain questions about the di-agnosis and treatment of Lyme Disease. In this article, what is known about the disease will be reviewed, and approaches to the successful diagnosis and treatment of Lyme disease described.<\/jats:p>\n                  <jats:p>In considering the diagnosis of Lyme disease, a major problem is the inability of documenting the existence and location of the bacteria. After the initial transfer of the bacteria from the Ixodes tick into the person, the spirochetes spread locally, but after an initial bacteremic phase, the organisms can no longer be reliably found in body fluids. The bacteria are proba-bly present in subcutaneous sites and intracellular loci. Currently, the use of circulating antibodies directed against spe-cific antigens of the Lyme borrelia are the standard means to diagnose the disease, but specific antibodies are not an ade-quate means to assess the presence or absence of the organism. What is needed is a more Lyme-specific antigen as a more definitive adjunct to the clinical diagnosis.<\/jats:p>\n                  <jats:p>\n                    As for the treatment of Lyme disease, the earliest phase is generally easily treated. But it is the more chronic form of the disease that is plagued with lack of information, frequently leading to erroneous recommendations about the type and du-ration of treatments. Hence, often cited recommendations about the duration of treatment, eg four weeks is adequate treatment, have no factual basis to support that recommendation, often leading to the conclusion that there is another, per-haps psychosomatic reason, for the continuing symptoms.\n                    <jats:italic>B. burgdorferi<\/jats:italic>\n                    is sensitive to various antibiotics, including pe-nicillins, tetracyclines, and macrolides, but there are a number of mitigating factors that affect the clinical efficacy of these antibiotics, and these factors are addressed. The successful treatment of Lyme disease appears to be dependent on the use of specific antibiotics over a sufficient period of time. Further treatment trials would be helpful in finding the best regimens and duration periods.\n                  <\/jats:p>\n                  <jats:p>At present, the diagnosis of Lyme disease is based primarily on the clinical picture. The pathophysiology of the disease remains to be determined, and the basis for the chronic illness in need of additional research. Whether there is continuing infection, auto-immunity to residual or persisting antigens, and whether a toxin or other bacterial-associated product(s) are responsible for the symptoms and signs remains to be delineated.<\/jats:p>","DOI":"10.2174\/1874205x01206010140","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T01:18:58Z","timestamp":1355188738000},"page":"140-145","update-policy":"https:\/\/doi.org\/10.2174\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Issues in the Diagnosis and Treatment of Lyme Disease"],"prefix":"10.2174","volume":"06","author":[{"given":"Sam T","family":"Donta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"refR1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.7043737","volume":"216","author":"Burgdorfer W","year":"1982","unstructured":"Burgdorfer W, Barbour AG, Hayes SF, et al. \n                    Lyme disease-a tick-borne spirochetosis? \n                    Science  \n                    1982; \n                    216\n                    : 1317-9.","journal-title":"Science"},{"key":"refR2","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1086\/648076","volume":"49","author":"Nowakowski J","year":"2009","unstructured":"Nowakowski J, McKenna D, Nadelman RB, et al. \n                    Blood cultures for patients with extracutaneous manifestations of Lyme disease in the United States \n                    Clin Infect Dis  \n                    2009; \n                    49\n                    : 1733-5.","journal-title":"Clin Infect Dis"},{"key":"refR3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM200107123450207","volume":"345","author":"Steere AC","year":"2001","unstructured":"Steere AC. \n                    Lyme Disease \n                    N Engl J Med  \n                    2001; \n                    345\n                    : 115-25.","journal-title":"N Engl J Med"},{"key":"refR4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/jcm.25.3.557-558.1987","volume":"25","author":"Piesman J","year":"1987","unstructured":"Piesman J, Mather TN, Sinsky RJ, et al. \n                    Duration of tick attachment and Borrelia burgdorferi transmission \n                    J Clin Microbiol  \n                    1987; \n                    25\n                    : 557-8.","journal-title":"J Clin Microbiol"},{"key":"refR5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJM200107123450201","volume":"345","author":"Nadelman RB","year":"2001","unstructured":"Nadelman RB, Nowakowski J, Fish D, et al. \n                    Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite \n                    N Engl J Med  \n                    2001; \n                    345\n                    : 79-84.","journal-title":"N Engl J Med"},{"key":"refR6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-117-4-273","volume":"117","author":"Nadelman RB","year":"1992","unstructured":"Nadelman RB, Luger SW, Frank E, et al. \n                    Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease \n                    Ann Intern Med  \n                    1992; \n                    117\n                    : 273-80.","journal-title":"Ann Intern Med"},{"key":"refR7","first-page":"209","volume":"339","author":"Steere AC","year":"1998","unstructured":"Steere AC, Sikand VK, Meurice F, et al. \n                    Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant \n                    Lyme Disease Vaccine Study Group N Engl J Med  \n                    1998; \n                    339\n                    : 209-15.","journal-title":"Lyme Disease Vaccine Study Group N Engl J Med"},{"key":"refR8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0025-7125(03)00090-7","volume":"86","author":"Donta ST","year":"2002","unstructured":"Donta ST. \n                    Chronic and Late Lyme Disease \n                    Med Clin North Am  \n                    2002; \n                    86\n                    : 341-9.","journal-title":"Med Clin North Am"},{"key":"refR9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000097332","volume":"4","author":"Clauw DJ","year":"1997","unstructured":"Clauw DJ, Chrousos GP. \n                    Chronic pain and fatigue syndromes:overlapping clinical and neuroendocrine features and potential pathogenic mechanisms \n                    Neuroimmunomodulation  \n                    1997; \n                    4\n                    (3\n                )\n                    : 134-53.","journal-title":"Neuroimmunomodulation"},{"key":"refR10","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1086\/516171","volume":"25","author":"Donta ST","year":"1997","unstructured":"Donta ST. \n                    Tetracycline therapy of chronic Lyme Disease \n                    Clin Infect Dis  \n                    1997; \n                    25\n                    : S52-6.","journal-title":"Clin Infect Dis"},{"key":"refR11","first-page":"136","volume":"9","author":"Donta ST","year":"2003","unstructured":"Donta ST. \n                    Macrolide Therapy of Chronic Lyme Disease \n                    Med Sci Monit  \n                    2003; \n                    9\n                    : 136-42.","journal-title":"Med Sci Monit"},{"key":"refR12","first-page":"590","volume":"44","year":"1995","unstructured":"Centers for Disease Control. \n                    Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease \n                    MMWR  \n                    1995; \n                    44\n                    : 590-1.","journal-title":"MMWR"},{"key":"refR13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/infdis\/167.2.392","volume":"167","author":"Dressler F","year":"1993","unstructured":"Dressler F, Whalen JA, Reinhardt BN, Steere AC. \n                    Western blotting in the serodiagnosis of Lyme disease \n                    J Infect Dis  \n                    1993; \n                    167\n                    : 392-400.","journal-title":"J Infect Dis"},{"key":"refR14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/RLU.0b013e318262ad9b","volume":"37","author":"Donta ST","year":"2012","unstructured":"Donta ST, Noto RB, Vento JA. \n                    SPECT Brain Imaging in Chronic Lyme Disease \n                    Clin Nuclear Med  \n                    2012; \n                    37\n                    (9\n                )\n                    : 219-2.","journal-title":"Clin Nuclear Med"},{"key":"refR15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-2478(00)00316-3","volume":"76","author":"Stricker RB","year":"2001","unstructured":"Stricker RB, Winger EE. \n                    Decreased CD57 lymphocyte subset in patients with chronic Lyme disease \n                    Immunol Lett  \n                    2001; \n                    76\n                    : 43-8.","journal-title":"Immunol Lett"},{"key":"refR16","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/labinvest.3780109","volume":"80","author":"Cadavid D","year":"2000","unstructured":"Cadavid D, O\u2019Neill T, Schaefer H, Pachner AR. \n                    Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of Lyme disease \n                    Lab Investig  \n                    2000; \n                    80\n                    : 1043-54.","journal-title":"Lab Investig"},{"key":"refR17","doi-asserted-by":"crossref","first-page":"e29914","DOI":"10.1371\/journal.pone.0029914","volume":"7","author":"Embers ME","year":"2012","unstructured":"Embers ME, Barthold SW, Borda JT, et al. \n                    Persistence of Borrelia burgdorferi in Rhesus Macaques following Antibiotic Treatment of Disseminated Infection \n                    PLoS One  \n                    2012; \n                    7\n                    (1\n                )\n                    : e29914.","journal-title":"PLoS One"},{"key":"refR18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/AAC.00788-09","volume":"54","author":"Barthold SW","year":"2010","unstructured":"Barthold SW, Hodzic E, Imai DM, et al. \n                    Ineffectiveness of tigecycline against persistent Borrelia burgdorferi \n                    Antimicrob Agents Chemother  \n                    2010; \n                    54\n                    : 643-51.","journal-title":"Antimicrob Agents Chemother"},{"key":"refR19","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/infdis\/166.5.1097","volume":"166","author":"Maurin M","year":"1992","unstructured":"Maurin M, Benoliel AM, Bongrand P, Raoult D. \n                    Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm \n                    J Infect Dis  \n                    1992; \n                    166\n                    : 1097-2.","journal-title":"J Infect Dis"},{"key":"refR20","author":"Donta ST","year":"1998","unstructured":"Donta ST, Martin SE, Meeting IDSA, Denver CO, Cartwright MJ. \n                    A Novel toxin (Bbtox1) of Borrelia burgdorferi \n                    Abstracts of Annual \n                    1998.","journal-title":"Abstracts of Annual"},{"key":"refR21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","volume":"345","author":"Klempner MS","year":"2001","unstructured":"Klempner MS, Hu LT, Evans J, et al. \n                    Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme Disease \n                    N Engl J Med  \n                    2001; \n                    345\n                    : 85-92.","journal-title":"N Engl J Med"},{"key":"refR22","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","volume":"70","author":"Fallon BA","year":"2008","unstructured":"Fallon BA, Keilp JG, Corbera KM, et al. \n                    A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy \n                    Neurology  \n                    2008; \n                    70\n                    : 992-1003.","journal-title":"Neurology"},{"key":"refR23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","volume":"433","author":"Rothstein JD","year":"2005","unstructured":"Rothstein JD, Patel S, Regan MR, et al. \n                    Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression \n                    Nature  \n                    2005; \n                    433\n                    : 73-.","journal-title":"Nature"},{"key":"refR24","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1126\/science.1211037","volume":"334","author":"Nguyen D","year":"2011","unstructured":"Nguyen D, Joshi-Datar A, Lepine F, et al. \n                    Active starvation responses mediate antibiotic tolerance in biofims and nutrient-limited bacteria \n                    Science  \n                    2011; \n                    334\n                    : 982-6.","journal-title":"Science"},{"key":"refR25","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1126\/science.1209855","volume":"334","author":"Shatalin K","year":"2011","unstructured":"Shatalin K, Shatalina E, Mironov A, et al. \n                    H2S: a universal defense against antibiotics in bacteria \n                    Science  \n                    2011; \n                    334\n                    : 986-.","journal-title":"Science"}],"container-title":["The Open Neurology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/openneurologyjournal.com\/contents\/volumes\/V06\/TONEUJ-6-140\/TONEUJ-6-140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openneurologyjournal.com\/contents\/volumes\/V06\/TONEUJ-6-140\/TONEUJ-6-140.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openneurologyjournal.com\/contents\/volumes\/V06\/TONEUJ-6-140\/TONEUJ-6-140.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:48:59Z","timestamp":1761547739000},"score":1,"resource":{"primary":{"URL":"https:\/\/openneurologyjournal.com\/VOLUME\/06\/PAGE\/140\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,30]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,11,30]]}},"alternative-id":["TONEUJ-6-140"],"URL":"https:\/\/doi.org\/10.2174\/1874205x01206010140","relation":{},"ISSN":["1874-205X"],"issn-type":[{"type":"print","value":"1874-205X"}],"subject":[],"published":{"date-parts":[[2012,11,30]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2012-4-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-6-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-7-2","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-11-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}